StockData
Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc. (ATOS) stock

ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.90−0.03 (-1.55%)

Close on Nov 17, 2026Market cap $18.96MP/E –Yield –

Atossa Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2014 it was $49.22K, up 745.6% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2014Dec 31, 2014$49.22K+745.6%
FY2013Dec 31, 2013$5.82K–

More Atossa Therapeutics figures

See a number that looks wrong?